Doctor profile · Federal record
Dr. Ann Strazdus, C.R.N.P.
Nurse Practitioner · Wilkes Barre, PA
- NPI 1063509669
- Accepts Medicare
- 25 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1130 Highway 315
Wilkes Barre, PA 187026952
(570) 823-8896
fax (570) 823-1291
Credentials & registration
- NPI registered
- October 2006 — 20 yrs on file
- Profile last updated
- July 8, 2007
- Year of graduation
- 2001 — 25 yrs since
- Specialty taxonomy
- 363L00000X — NUCC code
- State license (1)
- Pennsylvania #TP006994C
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1063509669. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
20,962
Distinct HCPCS
9
Medicare allowed
$451,160
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J3380 |
Injection, vedolizumab, 1 mg | 20,400 | 17 | $20 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 172 | 163 | $103 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 125 | 116 | $73 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 71 | 71 | $136 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 63 | 18 | $47 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 63 | 63 | $92 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 30 | 12 | $102 | |
99202 |
New patient office or other outpatient visit, 15-29 minutes | 22 | 22 | $59 | |
99442 |
Telephone medical discussion with physician, 11-20 minutes | 16 | 16 | $72 |
In context: peer comparison
Among 25 peers in Wilkes Barre Nurse Practitioner, average services per provider: 257. This provider delivers 82× the peer median.Open Payments
Industry payments received
All-time total
$2,200
Transactions
97
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 19 | $431.09 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | 22 | $339.62 | |
| Lilly USA, LLC | 12 | $207.30 | |
| Pfizer INC. | 9 | $165.11 | |
| Phathom Pharmaceuticals, INC. | 3 | $158.46 | |
| Genzyme Corporation | 1 | $124.66 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $124.43 | |
| Aimmune Therapeutics, INC. | 6 | $108.23 | |
| Janssen Biotech, INC. | 5 | $102.16 | |
| Regeneron Healthcare Solutions, INC. | 5 | $95.35 | |
| Ardelyx, INC. | 4 | $79.93 | |
| Takeda Pharmaceuticals U.S.A., INC. | 4 | $60.74 | |
| Ferring Pharmaceuticals INC. | 2 | $53.11 | |
| Organon LLC | 2 | $47.37 | |
| Intercept Pharmaceuticals, INC. | 2 | $40.85 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,111
Patients
259
Total drug cost
$283,531
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Omeprazole | Generic | 293 | 90 | $3,867 |
| Famotidine | Generic | 292 | 86 | $5,789 |
| Pantoprazole Sodium | Generic | 105 | 34 | $1,505 |
| Cholestyramine (Cholestyramine (With Sugar)) | Brand | 59 | 11 | $4,837 |
| Linzess (Linaclotide) | Brand | 54 | 11 | $41,386 |
| Azathioprine | Generic | 41 | 0 | $1,169 |
| Xifaxan (Rifaximin) | Brand | 38 | 0 | $123,364 |
| Dicyclomine Hcl | Generic | 34 | 13 | $705 |
| Metoclopramide Hcl | Generic | 31 | 0 | $346 |
| Balsalazide Disodium | Generic | 30 | 0 | $3,141 |
Hospital affiliations
Frequently asked questions
What is Dr. Ann Strazdus's medical specialty?
Dr. Ann Strazdus practices Nurse Practitioner in Wilkes Barre, PA.
Where does Dr. Ann Strazdus practice?
Dr. Ann Strazdus practices at 1130 Highway 315, Wilkes Barre, PA 187026952. Office phone: 5708238896.
What is Dr. Ann Strazdus's NPI?
Dr. Ann Strazdus's National Provider Identifier (NPI) is 1063509669, issued by NPPES.
Does Dr. Ann Strazdus accept Medicare assignment?
Yes. Dr. Ann Strazdus accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Ann Strazdus commonly perform?
Top Medicare-reported procedures in 2023: Injection, vedolizumab, 1 mg (HCPCS J3380); Established patient office or other outpatient visit (HCPCS 99214); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.